Introduction
In 1912, a British neurologist, Samuel Wilson, described a neurologic disorder with pathologic findings of degeneration of the lenticular nucleus in the brain and hepatocytes in the liver. It was then called progressive hepatolenticular degeneration, better known by its eponym, Wilson disease (WD). 1, 2, 4 WD is attributed to a rare autosomal recessive genetic defect on ATP7B, a metal-transporting P-type adenosine triphosphate on chromosome 13q14.3. Deficiency or absence of the transporter protein results to decreased biliary excretion of copper and thereby excessive deposition of copper in the liver, central nervous system, cornea, kidney, and cardiac muscles. 3 WD has a prevalence rate of 15 to 30 cases per million, qualifying as a rare disease based on the criterion of European Commission on Public Health and Institute of Human Genetics. 4 The manifestations of WD are more likely to be hepatic in early childhood, and neurologic in adolescents and young adults. WD has varied presentations, classified into three movement disorder syndromes: 1. Dystonia (dystonic postures and choreoathethosis) 2. Ataxia (ataxia with postural and intentional tremors) 3. Parkinsonian symptoms (hypokinesia, rigidity, and resting tremors) F r e e p a p e r Emphasis should be given to reviewing vignettes, diagnostics, and treatment of patients in order to catch these rare conditions early and subsequently initiate treatment. We present two vignettes of WD.
Clinical vignettes

Case 1
A 20-year-old female presented with 12-month history of slowing of movement and difficulty writing legibly, with occasional reports of postural tremors, right more than the left and blurring of vision. She developed slurring of speech and involuntary hand movements.
Pertinent neurologic examination revealed a MiniMental Status Examination (MMSE) score of 29/30, with deficit in attention and choreiform movements in upper and lower extremities coupled with athetoid movements of the hands. Classic wing-beating tremors were observed in the right arm. On passive range of motion, there was mild rigidity, right more than the left, and bradykinesia noted on rapid fine movements of fingers. Generalized hyperreflexia and tendency to fall backward on walking were observed.
Case 2
A 21-year-old female presented initially with spontaneous abortion, and then had slurring of speech and stiffness of the jaw, with occasional reports of cramps of facial muscles. She then developed tremors and stiffening of right extremities, which progressed to involve the contralateral side with accompanying weakness over a span of 18 months. Over the succeeding 4 months, there was progression of stiffness causing posturing of legs and difficulty ambulating, and worsening kinetic tremors. There were also episodes of freezing of gait and uncontrolled grin.
Relevant neurologic findings were: MMSE of 27/28, with deficit in recall. Poor gutturals and tongue fasciculations were noted on cranial nerve examination. There was marked atrophy of the intrinsic muscles of the hand and posterior leg muscles with paradoxical hypertrophy of triceps and quadriceps. Dystonic inversion posturing of both feet was notable on walking. The patient also had generalized rigidity and kinetic tremors, more prominent on the right than the left.
Diagnostic workup
The two cases were worked up for WD and can be classified differently; the first case falls into the ataxic type with parkinsonian symptoms and the second case fits the dystonic with parkinsonian symptoms (Table I) . 5, 6 Both of the patients were subjected to slit-lamp examination revealing the presence of Kayser-Fleischer rings ( Figure 1) . A complete hepatic workup was done, revealing normal liver function: transaminases and clotting factors but with gross structural abnormalities noted on sonography (Table II) low ceruloplasmin, and increased urinary excretion of copper. 7, 8, 9, 10 Genetic testing was not done on these patients.
Magnetic resonance imaging of the brain did not reveal the typical double panda sign but showed symmetrical T2/FLAIR hyperintensities over the putamen, caudate and thalami nucleus (Figure 2 and Figure 3) . 11, 12 Both findings were highly suggestive of mineral deposition. Furthermore, following the scoring by Leipzig et al, the two vignettes are definite cases of WD. 8, 13, 16 Because of the rarity of the disease, it is not cost-effective to initiate population-based screening. Screening however should be compulsory for patients presenting with unexplained neurological 
Management
As for the treatment, definitive treatment includes liver transplantation, especially for those with acute hepatitis or fulminant hepatic failure. For those with serious and debilitating neurologic sequelae, the best option is either to increase urinary excretion of cooper directly ie, D-penicillamine and trientine or block gastrointestinal absorption of copper ie, zinc acetate/salts and tetrathiomolybdate (Table III) . 14, 15, 16, 17 For both cases, low copper diet was a mainstay of treatment. Zinc supplementation was also initiated, with subsequent noting of remarkable improvements in speech, tremors, and stiffening of extremities. The first case underwent D-penicillamine treatment with slow uptitration of the drug to avoid hematologic consequences and to monitor for paradoxical neurological deterioration. As for the second case, the patient was maintained on zinc supplementation because of relatively severe baseline neurologic status and high risk for paraxodical neurologic worsening. Treatment should still be individualized since no two patients with WD are the same. 8, 15, 16 For patients with debilitating movement disorder refractory to chelation and medical treatment, botulinum toxin injection maybe offered. Screening of siblings of the patient and monitoring of their serum ceruloplasmin is also a big part of management. 18 Early intervention signifies better prognosis, thus can be considered as a therapeutic emergency as well.
Synthesis
Educating medical doctors about this neurologic condition and having a high index of suspicion can improve treatment of this debilitating condition. Familiarization of this rare genetic conditions may also pave way for future researches to ascertain the prevalence, to facilitate detection and to improve outcomes. o Disclosure/Acknowledgments: Dr Porlas, Dr de Castillo, and Dr Dioquino have nothing to disclose.
